You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor microenvironment (TME)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in United States (Nemvaleukin alfa, Pembrolizumab)

Recruiting
  • Advanced Solid Tumor
  • Nemvaleukin alfa
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +3 more
Aug 30, 2022

Tumor Microenvironment Analysis of Prostate Cancer Metastasis

Recruiting
  • Recurrent Prostate Cancer
  • Biopsy
  • New York, New York
    Columbia University Medical Center
Mar 22, 2022

Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2023

The Tumor Microenvironment for Locally Advanced Resectable

Recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • non-intervention
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Mar 24, 2022

Tumor Microenvironment

Active, not recruiting
  • Lung Adenocarcinoma
    • (no location specified)
    Aug 5, 2023

    Multiple Myeloma Cells From miRNAs Released From B Cells, and

    Recruiting
    • Multiple Myeloma
      • Aviano, Pordenone, Italy
        Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
      Nov 23, 2023

      Role of the Tumor Microenvironment in Aggressive Meningiomas

      Not yet recruiting
      • Meningioma
      • Surgical waste and Data collect
      • (no location specified)
      Apr 7, 2023

      Cancer of the Colon Trial in Marseille (BLOOD AND TUMOR)

      Recruiting
      • Cancer of the Colon
      • BLOOD AND TUMOR
      • Marseille, France
        Institut Paoli Calmettes
      Jul 12, 2023

      Esophageal Cancer Trial in Wuhan

      Recruiting
      • Esophageal Cancer
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 7, 2023

        LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

        Not yet recruiting
        • Relapsed Non-Hodgkin Lymphoma
          • (no location specified)
          Sep 19, 2023

          Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

          Not yet recruiting
          • Squamous Cell Carcinoma of Head and Neck
          • fMRI
          • Oral Pimonidazole
          • Toronto, Ontario, Canada
            Princess Margaret Cancer Center
          Oct 9, 2023

          Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

          Recruiting
          • Oncology
          • moderate Whole Body Hyperthermia (mWBH)
          • Berlin, Germany
            Klinik für Radioonkologie und Strahlentherapie
          Apr 6, 2023

          Tumor and Peripheral Blood to Evaluate Efficacy of Cancer

          Recruiting
          • Lung Cancer
          • Esophageal Cancer
          • In vitro stimulation of Pbmc with tumor antigen nanoparticles
          • Suzhou, Jiangsu, China
            The first affiliated hospital of soochow university
          Mar 16, 2023

          Prospective Procurement of Tumor Tissue to Identify Novel

          Enrolling by invitation
          • Solid Tumors
          • +7 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Feb 2, 2023

            Radiotherapy - Comprehensive Radiobiology Assessment TRial

            Not yet recruiting
            • Locally Advanced Cervical Carcinoma
            • +9 more
              • Saint Louis, Missouri
                Washington University School of Medicine
              Aug 1, 2023

              GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

              Not yet recruiting
              • GastroEsophageal Cancer
                • Lyon, France
                  Centre Léon Bérard
                Dec 1, 2022

                The CSTME Associates With Prognosis of Stage II and III

                Completed
                • Colorectal Cancer
                • CSTME
                • Guangzhou, Guangdong, China
                  Nanfang Hospital
                Jun 12, 2022

                Locally Advanced Rectal Cancer Trial (PD-1 inhibitor, Capecitabine, Long-course radiation therapy)

                Not yet recruiting
                • Locally Advanced Rectal Cancer
                • PD-1 inhibitor
                • +2 more
                • (no location specified)
                Aug 16, 2022

                The Tumor Microenvironment in Advanced Gastric Cancer

                Recruiting
                • Gastric Cancer
                • non-intervention
                • Guangzhou, Guangdong, China
                  Nanfang Hospital, Southern Medical University
                Mar 24, 2022

                Triple Negative Breast Cancer Trial in New York (Merck 3475 Pembrolizumab, Intraoperative radiation therapy (IORT))

                Recruiting
                • Triple Negative Breast Cancer
                • Merck 3475 Pembrolizumab
                • Intraoperative radiation therapy (IORT)
                • New York, New York
                  Columbia University Irving Medical Center
                Oct 10, 2022

                Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)

                Not yet recruiting
                • Gastric Adenocarcinoma
                • Gastroesophageal Junction Adenocarcinoma
                • Tadalafil 20 MG
                • Tucson, Arizona
                  Arizona Cancer Center at UMC North/University Medical Center
                Feb 1, 2023

                Endometrial Cancer Trial in Hong Kong (Olaparib)

                Not yet recruiting
                • Endometrial Cancer
                • Hong Kong, Hong Kong
                  The University of Hong Kong
                Apr 2, 2022

                Immunophenotypic Evaluation of IL-7R a in Acute Leukaemia

                Not yet recruiting
                • Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder
                  • (no location specified)
                  Nov 30, 2022

                  Simultaneous Liver Metastases Extensive Stage Small Cell Lung

                  Completed
                  • Extensive Stage Small Cell Lung Cancer
                  • First line EC/EP+Atezolizumab
                  • Changsha, Hunan, China
                    Hunan Cancer Hospital
                  Jan 22, 2022

                  Ovarian Cancer Trial in Roma (Blood sample)

                  Recruiting
                  • Ovarian Cancer
                  • Blood sample
                  • Roma, Italy
                    Policlinico Universitario Agostino Gemelli
                  Oct 10, 2023